Abstract
Transmissible subacute spongiform encephalopathies (TSSE) form a group of fatal neurodegenerative diseases which include Creutzfeldt-Jakob disease in humans, scrapie in sheep and goats and bovine spongiform encephalopathy (BSE) in cattle. They are characterized by a long incubation period which precedes clinical symptoms related to the central nervous system (CNS) degeneration. In experimental models, a modified proteinase-resistant form (PrPres) of a host-encoded protein (PrP) accumulates in the brain proportionally to infectivity1,2. A transcriptional overexpression of glial fibrillary acidic protein (GFAP), a specific marker of astrocytes, has also been observed3,4,5.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
S. B. Prusiner, Novel proteinaceous infectious particles cause scrapie, Science. 216: 136 (1982).
D. C. Bolton, M. P. McKinley, and S. B. Prusiner, Identification of a protein that purifies with the scrapie prion, Science. 218: 1309 (1982).
D. Dormont, B. Delpech, A. Delpech, M. N. Courcel, J. Viret, P. Markovits, and L. Court, Hyperproduction de protéine gliofibrillaire acide (GFAP) au cours de l’évolution de la tremblante expérimentale de la souris, C R Acad Sc Paris. 293: 53 (1981).
F. Lazarini, J. P. Deslys, and D. Dormont, Variations in prion protein and glial fibrillary acidic protein messenger RNAs in the brain of scrapie-infected newborn mouse, J Gen Virol. 73: 1645 (1992).
A. Mackenzie, Immunohistochemical demonstration of glial fibrillary acidic protein in scrapie, J Comp Pathol. 93: 251 (1983).
P. Brown, A therapeutic panorama of the spongiform encaphalopathies, Antiviral Chemistry & Chemoth. 1: 75 (1990).
R. H. Kimberlin, and C. A. Walker, The antiviral compound HPA-23 can prevent scrapie when administred at the time of infection, Arch Virol 78: 9 (1983).
R. H. Kimberlin, and C. A. Walker, Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulfate, and some other polyanions, Antimicrob Agents Chemother. 30: 409 (1986).
L. Ingrosso, A. Ladogana, and M. Pocchiari, Congo red prolongs the incubation period in scrapie-infected hamsters, J Virol. 69: 506 (1995).
H. Amyx, A. M. Salazar, D. C. Gajdusek, and C. J. Gibbs, Chemotherapeutic trials in experimental slow virus disease, Neurology. 34: 149 (1984).
M. Pocchiari, S. Schmittinger, A. Ladogana, and C. Masullo, Effects of Amphotericin B in intracerebrally scrapie inoculated hamster, in Unconventional Virus Diseases of the Central Nervous System, L.A. Court, D. Dormont, P. Brown and D.T. Kingsbury, eds., C.E.A. diffusion, Paris (1986).
M. Pocchiari, S. Schmittinger, and C. Masullo, Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters, J Gen Virol. 68: 219 (1987).
M. Pocchiari, P. Casaccia, and A. Ladogana, Amphotericin B: a novel class of antiscrapie drugs, J Infect Dis. 160: 795 (1989).
R. T. Proffitt, A. Satorius, S. M. Chiang, L. Sullivan, and J. P. Adler-Moore, Pharmacology and toxicology of a liposomal formulation of amphotericin B (Ambisome) in rodents, J Antimicrob Chemother. 28, Suppl. B: 49 (1991).
E. S. Tabosa Do Egito, M. Appel, H. Fessi, G. Barratt, F. Puisieux, and J. P. Devissaguet, in-vitro and in-vivo evaluation of a new amphotericin B emulsion-based delivery system, J Antimicrob Chemother. 38: 485 (1996).
Y. G. Xi, L. Ingrosso, A. Ladogana, C. Masullo, and M. Pocchiari, Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation, Nature. 356: 598 (1992).
D. McKenzie, J. Kaczkowski, R, Marsh, and J. Aiken, Amphotericin B delays scrapie agent replication and PrP-res accumulation early in infection, J Virol. 68: 7534 (1994).
M. Magierowskajung, D. Cefai, H. Marrakchi, F. Chieze, H. Agut, J. M. Huraux, and M. Seman, In vitro determination of antiviral activity of MS-8209, a new amphotericin B derivative, against primary isolates of HIV 1, Res Virol. 147: 313 (1996).
O. Pleskoff, N. Sol, H. Marrakchi, M. Serlin, M. Seman, and M. Alizon, Possible role of the V3 domain of gp 120 in resistance to an Amphotericin B derivative (MS-8209) blocking human immunodefiency virus entry, J Virol 70: 8247 (1996).
L. Saint-Julien, V. Joly, M. Seman, C. Carbon, and P. Yeni, Activity of MS-8209, a nonester Amphotericin B derivative, in treatment of experimental systemic mycoses, Antimicrob Agents Chemother. 36:2722 (1992).
C. I. Lasmézas, J. P. Deslys, R. Demaimay, K. T. Adjou, J. J. Hauw, and D. Dormont, Strain specific and common pathogenic events in murine models of scrapie and bovine spongiform encephalopathy, J Gen Virol 77:1601 (1996).
C. I. Lasmézas, J. P. Deslys, O. Robain, A. Jaegly, V. Beringue, J. M. Peyrin, J. G. Fournier, J. J. Hauw, J. Rossier, and D. Dormont, Transmission of BSE agent to mice in the absence of detectable abnormal prion protein, Science. 275:402 (1997).
L. J. Reed, and H. Muench, A simple method of estimating fifty percent endpoints, Amer J Hygiene. 27:493 (1938).
S. B. Prusiner, S. P. Cochran, D. F. Groth, D. E. Downey, K. A. Bowman, and H. M. Martinez, Measurement of the scrapie agent using an incubation time interval assay, Ann Neurol. 11:353 (1982).
K. T. Adjou, R. Demaimay, C. I. Lasmézas, J. P. Deslys, M. Seman, and D. Dormont, MS-8209, a new amphotericin B derivative, provides enhanced efficacy in delaying hamster scrapie, Antimicrob Agents Chemother. 39:2810 (1995).
R. Demaimay, K. T. Adjou, V. Beringue, S. Demart, F. Lamoury, C. I. Lasmézas, J. P. Deslys, M. Seman, and D. Dormont, Polyene antibiotics in experimental transmissible spongiform encephalopathies, in Transmissible Subacute Spongiform Encephalopathies: Prion Diseases, L. Court and B. Dodet, eds., Elsevier, Paris (1996).
R. Demaimay, K. T. Adjou, C. I. Lasmézas, F. Lazarini, K. Cherifi, M. Seman, J. P. Deslys, and D. Dormont, Pharmalogical studies of a new derivative of Amphotericin B, MS-8209, in mouse and hamster scrapie, J Gen Virol 75, 2499 (1994).
K. T. Adjou, R. Demaimay, C. I. Lasmézas, M. Seman, J. P. Deslys, and D. Dormont, Differential effects of a new Amphotericin B derivative, MS-8209, on mouse BSE and scrapie: Implications for the mechanism of action of polyene antibiotics, Res Virol. 147:213 (1996).
R. I. Carp, Scrapie, unconventional infectious agent, in Neuropathogenic Viruses and Immunity, S. Specter, ed., Plenum Press, New-York (1992).
M. Pocchiari, L. Ingrosso, and A. Ladogana, Effect of Amphotericin B on different experimental strains of spongiform encephalopathy agents, in Bovine Spongiform Encephalopathy: the BSE Dilemma, C. J. Gibbs Jr, ed., Springer Verlag, New-york (1996).
K. T. Adjou, J. P. Deslys, R. Demaimay, and D. Dormont, Probing the dynamics of prion diseases with Amphotericin B, Trends Microb. 5:27 (1997).
R. H. Kimberlin, and C. A. Walker, Pathogenesis of mouse scrapie: effect of route of inoculation on infectivity titres and dose-response curves, J Comp Pathol. 88:39 (1978).
R. H. Kimberlin, and C. A. Walker, Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after infection by different routes, J Comp Pathol. 89:551 (1979).
R. H. Kimberlin, and C. A. Walker, Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly, J Gen Virol. 67:255 (1986b).
H. Diringer, and B. Ehlers, Chemoprophylaxis of scrapie in mice, J Gen Virol. 72:457 (1991).
B. Ehlers, and H. Diringer, Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen, J Gen Virol. 65:1325 (1984).
A. Ladogana, P. Casaccia, L. Ingrosso, M. Cibati, M. Salvatore, Y. G. Xi, C. Masullo, and M. Pocchiari, Sulphate polyanions prolong the incubation period of scrapie-infected hamsters, J Gen Virol. 73:661 (1992).
H. A. Gallis, R. H. Drew, and W. W. Pickard, Amphotericin B: 30 years of clinical experience, Reviews of Infectious Diseases. 12:308 (1990).
Y. L. Chung, A. Williams, J. S. Beech, S. C. R. Williams, J. D. Bell, J. Cox, and J. Hope, MRI assessment of the blood-brain barrier in a hamster model of scrapie, Neurodegeneration. 4:203 (1995).
F. C. Szoka, and M. Tang, Amphotericin B formulated in liposomes and lipid based systems: a review, J Liposome Res. 3:363 (1993).
A. Vertut-Doï, S. I. Ohnishi, and J. Bolard, The endocytic process in CHO cells, a toxic pathway of the polyene antibiotic Amphotericin B, Antimicrob Agents Chemother. 38:2373 (1994).
B. Chesebro, and B. Caughey, Scrapie agent replication without the prion protein, Curr Biol. 3:696 (1993).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Beringue, V. et al. (1998). Polyene Antibiotics in Experimental Transmissible Subacute Spongiform Encephalopathies. In: Morrison, D.R.O. (eds) Prions and Brain Diseases in Animals and Humans. NATO ASI Series, vol 295. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1896-3_18
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1896-3_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1898-7
Online ISBN: 978-1-4899-1896-3
eBook Packages: Springer Book Archive